Singapore also secured six major biologics investments over the last few years totaling about S$2.5 billion from Roche, Lonza, GlaxoSmithKline, Novartis and Baxter, which could potentially create about 1,300 new jobs” (MOH, 2009).
What exactly is biologics?
Biologics is a subset of manufacturing processes which also comprises of pharmaceuticals and nutritionals. They are medicinal products manufactured from [...]

Within a short span of 2 years, 4 major biomedical companies announced their commercial-scale biologics manufacturing investments in Singapore. These investments include, GlaxoSmithKline’s Biologics’ vaccine plant, Lonza’s two mammalian cell culture facilities, Novartis cell culture plant and Genentech microbial facility.
So what made these companies come to Singapore?
Firstly, it was due to the country’s heavy investments [...]

“Every patient is special.”

This is the foundation behind drug development and production. The pharmaceutical industry has to follow heavy regulations and guidelines to ensure the products are safe for consumption and the process adopted for manufacturing is reliable. The nature of this industry calls for the highest standards of production precision and accurate product and [...]